Literature DB >> 11673530

The MHC-specific enhanceosome and its role in MHC class I and beta(2)-microglobulin gene transactivation.

S J Gobin1, M van Zutphen, S D Westerheide, J M Boss, P J van den Elsen.   

Abstract

The promoter regions of MHC class I and beta(2)-microglobulin (beta(2)m) genes possess a regulatory module consisting of S, X, and Y boxes, which is shared by MHC class II and its accessory genes. In this study we show that, similar to MHC class II, the SXY module in MHC class I and beta(2)m promoters is cooperatively bound by a multiprotein complex containing regulatory factor X, CREB/activating transcription factor, and nuclear factor Y. Together with the coactivator class II transactivator this multiprotein complex drives transactivation of these genes. In contrast to MHC class II, the multiprotein complex has an additional function in the constitutive transactivation of MHC class I and beta(2)m genes. The requirement for all transcription factors in the complex and correct spacing of the binding sites within the SXY regulatory module for complex formation and functioning of this multiprotein complex strongly suggests that this complex can be regarded as a bona fide enhanceosome. The general coactivators CREB binding protein, p300, general control nonderepressible-5, and p300/CREB binding protein-associated factor exert an ancillary function in MHC class I and beta(2)m transactivation, but exclusively through the class II transactivator component of this enhanceosome. Thus, the SXY module is the basis for a specific enhanceosome important for the constitutive and inducible transactivation of MHC class I and beta(2)m genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673530     DOI: 10.4049/jimmunol.167.9.5175

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  NLRC5/CITA: A Key Player in Cancer Immune Surveillance.

Authors:  Sayuri Yoshihama; Saptha Vijayan; Tabasum Sidiq; Koichi S Kobayashi
Journal:  Trends Cancer       Date:  2017-01-10

Review 3.  Molecular evolution of elements controlling HLA-C expression: Adaptation to a role as a killer-cell immunoglobulin-like receptor ligand regulating natural killer cell function.

Authors:  Stephen K Anderson
Journal:  HLA       Date:  2018-11       Impact factor: 4.513

4.  Conditioned taste aversion dependent regulation of amygdala gene expression.

Authors:  Siva K Panguluri; Nobuyuki Kuwabara; Yi Kang; Nigel Cooper; Robert F Lundy
Journal:  Physiol Behav       Date:  2011-11-13

5.  Identification of trophoblast-specific elements in the HLA-C core promoter.

Authors:  Jenna K Johnson; Paul W Wright; Hongchuan Li; Stephen K Anderson
Journal:  HLA       Date:  2018-10-30       Impact factor: 4.513

Review 6.  Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Authors:  Saptha Vijayan; Tabasum Sidiq; Suhail Yousuf; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Immunogenetics       Date:  2019-01-31       Impact factor: 2.846

7.  Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2.

Authors:  Hong Jiang; Ping Wang; Xiaohua Li; Qilong Wang; Zhong-Bin Deng; Xiaoying Zhuang; Jingyao Mu; Lifeng Zhang; Baomei Wang; Jun Yan; Donald Miller; Huang-Ge Zhang
Journal:  Cancer Immunol Res       Date:  2014-05-06       Impact factor: 11.151

Review 8.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

9.  Tumor necrosis factor α-induced hypoxia-inducible factor 1α-β-catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling.

Authors:  Sadashib Ghosh; Arkoprovo Paul; Ellora Sen
Journal:  Mol Cell Biol       Date:  2013-05-13       Impact factor: 4.272

10.  In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.

Authors:  Philippe Rousseau; Krzysztof Masternak; Michal Krawczyk; Walter Reith; Jean Dausset; Edgardo D Carosella; Philippe Moreau
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.